IgG antibodies can suppress more than 99% of the antibody response against the antigen to which they bind. This is used clinically to prevent rhesus-negative (Rh ؊ ) women from becoming immunized against Rh ؉ erythrocytes from their fetuses. The suppressive mechanism is poorly understood, but it has been proposed that IgG͞erythrocyte complexes bind to the inhibitory 
The ability of antibodies to inhibit induction of immunity has been known for almost a century. It was shown in 1909 that an excess of antitoxin inhibited development of immunity to diphtheria toxin in guinea pigs (1) . In a system studying the antibody response in mice after immunization with sheep erythrocytes (SRBC), Henry and Jerne demonstrated that the molecules responsible for feedback inhibition of antibody responses were IgG antibodies (2) . The ability of passively administered IgG to suppress immune responses since has been studied intensively. Microgram amounts of IgG can suppress more than 99% of a primary antibody response against SRBC (2, 3) , whereas the suppressive effect on induction of immunological memory and a secondary antibody response is less pronounced (4) (5) (6) (7) . Suppression is induced by all murine IgG subclasses and is strictly antigen-specific, i.e., only the response to an antigen to which IgG can bind is affected (3, 8) . The ability of IgG to suppress immune responses has been applied clinically in the so-called rhesus (Rh) prophylaxis. Rh Because IgG antibodies are transported actively via the placenta from mother to young, such antibodies can damage fetal erythrocytes (reviewed in ref. 9 ). To prevent this, IgG anti-Rh is administered routinely to Rh Ϫ women during pregnancy or immediately after delivery of an Rh ϩ baby. This treatment inhibits the production of maternal anti-Rh antibodies and has brought the incidence of hemolytic disease of the newborn down dramatically since it was first introduced in the 1960s (10) .
Several models explaining antibody feedback suppression have been suggested. One is that passively administered IgG antibodies mask antigenic epitopes, thus preventing B cells from recognizing and responding to the antigen. Other models postulate the involvement of receptors for the Fc part of IgG (Fc␥Rs). IgG͞antigen complexes may be more rapidly eliminated by Fc␥R ϩ phagocytes than antigen alone. Alternatively, Fc␥RIIB, which is the only IgG receptor expressed on B cells, may be involved. Fc␥RIIB contains a cytoplasmic inhibitory motif (immune-receptor tyrosine-based inhibition motif or ITIM), which, when brought in proximity to receptors containing a specific activation motif (immune-receptor tyrosinebased activation motif or ITAM), inhibits cell activation through the latter (reviewed in ref. 11) . ITAMs are present in the B cell receptor (BCR), and it has been shown in vitro that co-cross-linking of Fc␥RIIB and BCR inhibits B cell activation (12) (13) (14) (15) (16) ). An attractive hypothesis explaining negative feedback regulation of in vivo antibody responses is ITIM-mediated inhibition of B cells, resulting from co-cross-linking of Fc␥RIIB and BCR by the IgG͞antigen complexes.
To understand the mechanism behind feedback suppression it is therefore important to determine whether or not suppression is dependent on the Fc part of the IgG molecule. Although a simple question, it has proven a difficult one to answer unequivocally in experimental systems. The most straightforward way of analyzing this is to compare the suppressive ability of intact IgG with that of F(abЈ) 2 fragments (where the Fc part has been proteolytically cleaved off). Such studies performed in vivo have given discrepant results, some claiming that F(abЈ) 2 fragments are less suppressive (4, 8, 17, 18) and others claiming that they are equally suppressive as intact IgG (19, 20) . An indirect way of assessing Fc dependence has been to study whether or not suppression is epitope-specific. Suppression of the response only to the epitope recognized by IgG (21, 22) has been interpreted as evidence for the epitope-masking hypothesis whereas suppression of the response to all epitopes on the antigen (3, 8, 18, 23) was considered to indicate Fc dependence. The unresolved question of Fc dependence of IgG-mediated suppression is analyzed here in a novel system, using Fc␥R-deficient (Fc␥R Ϫ͞Ϫ ) mice. Our results strongly suggest that IgG is able to efficiently suppress antibody responses independently of the Fc part. A way of interpreting available experimental data that can explain many of the discrepancies in the literature is presented.
MATERIALS AND METHODS
Antigens. SRBC and horse erythrocytes (HRBC) were purchased from The National Veterinary Institute (Uppsala, Sweden) and stored in sterile Alsevers solution at 4°C. For 2,4,6-trinitrophenyl (TNP) conjugation, a mixture of 1 ml packed SRBC, 1.5 ml dH 2 O, 1.75 ml of 0.56 M cacodylate buffer (cacodylic acid sodium salt; Sigma), pH 6.9, and 2 ml of a 12.5-mg͞ml solution of TNP (picrylsulfonic acid hydrate; Sigma) was incubated at room temperature for 1 hr. The cells then were washed once in PBS, once in glycyl-glycine (1 mg͞ml in PBS) (Merck), and three times in PBS before use. TNP and 5-iodo-4-hydroxyl-3-nitrophenacetyl (NIP) (NIP-CAP-Osu; Cambridge Research Biochemicals) were conjugated to BSA (Sigma) and SRBC as described (24, 25) . Soluble antigens were dialyzed against PBS, sterile-filtered, and stored at 4°C.
Antibodies and F(ab) 2 Fragments. Polyclonal IgG anti-SRBC were prepared from hyperimmune mouse sera. mAbs were derived from culture supernatants of B cell hybridomas producing IgG1 anti-TNP (B8401H5, H5), IgG2a anti-TNP (C4007B4, 7B4), IgG2b anti-TNP (C1901B4, 1B4) (26), or IgE anti-TNP (IGELb1, IGELb4, and IGELa2) (27) . IgG from serum or supernatants was purified on a protein A-Sepharose column (Pharmacia) (28) and IgE was purified on a Sepharose column coupled with monoclonal rat anti-mouse (24) . F(abЈ) 2 fragments were prepared by digesting purified IgG2a (7B4) with pepsin (Sigma) at an enzyme͞antibody ratio of 1:100, pH 3.5, for 12 hr at 37°C. The digested material then again was passed over a protein A-Sepharose column to remove intact IgG. The nonbound fraction was tested for remaining undigested IgG2a in ELISA (24) on plates coated with BSA-TNP detecting bound antibody with a biotinylated anti-IgG2a antibody (Southern Biotechnology Associates) (Fig. 3A) . The hemagglutination units are defined as the reciprocal of the highest antibody dilution able to agglutinate a 0.125% suspension of SRBC-TNP after 1-hr incubation at 37°C. Antibody concentrations were determined by absorbance at 280 nm (OD of 1.5 was assumed to equal 1 mg͞ml of antibody). All antibodies used were dialyzed against PBS, sterile-filtered, and stored at Ϫ20°C. Immunizations. Mice were immunized in their tail veins with 0.2 ml antigen͞antibody complexes formed by incubating antigen and antibodies (or antigen and PBS for controls) for 1 hr at 37°C immediately before injection. In a few experiments, as indicated, antigen and antibody were administered separately: 0.1 ml antibody followed within 1 hr by 0.1 ml antigen in PBS i.v.
Mice. Founders for the Fc␥RIIB
Adoptive Transfers. Adoptive transfers were conducted 5 months after primary immunization. Spleen cells (4 ϫ 10 7 ) from donors primed with IgG and SRBC, primed with SRBC alone, or left unimmunized were transferred i.v. in 0.2 ml PBS to syngeneic, irradiated recipients (600 rad, 24 hr earlier). Thirty minutes later, 4 ϫ 10 7 SRBC-NIP in 0.1 ml PBS was administered i.v.
Plaque-Forming Cell (PFC) and Enzyme-Linked Immunospot (ELISPOT) Assays. A modified version of the Jerne hemolytic PFC assay (32) was used. One hundred microliters of a spleen cell suspension from the mouse to be tested, 25 l of a 10% SRBC or HRBC suspension, and 25 l of guinea pig serum (as a source of complement, diluted 1:4) (The National Veterinary Institute, Uppsala, Sweden) were added to 300 l of 0.5% agarose [50% Seaplaque GTG (low melting point, Amersham) and 50% agarose (United States Biochemical)] Proc. Natl. Acad. Sci. USA 96 (1999) kept at 45°C. The mixture was spread quickly on a microscope slide and incubated in a humid chamber for 3 hr at 37°C. All dilutions were made in Hanks' balanced salt solution. Duplicate samples were counted ''blindly'' under a magnifying glass. The ELISPOT assays for measuring SRBC and NIP responses have been described in detail (25, 33) . Briefly, ELISA plates were coated with SRBC or BSA-NIP. Spleen cells suspended in cell culture medium were applied and incubated at 37°C for 3 hr. Antibodies produced by the cells were visualized as spots after the addition of sheep anti-mouse IgG-alkaline phosphatase (Jackson ImmunoResearch) and the precipitating substrate BCIP (5-bromo-4-chloro-3-indolyl phosphate; Sigma). Statistical analyses were performed with Student's t test, and P values are presented as not significant (ns), P Ͼ 0.05; ‫,ء‬ P Ͻ 0.05; ‫,ءء‬ P Ͻ 0.01; or ‫,ءءء‬ P Ͻ 0.001.
RESULTS
IgG-Mediated Suppression in Mice Lacking Fc␥RIIB. Fc␥RIIB binds IgG1, IgG2a, and IgG2b (but not IgG3) and is the only Fc␥R on B cells (reviewed in ref. 34 ). This receptor is involved in endocytosis and phagocytosis and can also negatively regulate cell activation, as described in the Introduction. To test the involvement of Fc␥RIIB in IgG-mediated suppression, we immunized Fc␥RIIB Ϫ͞Ϫ and wild-type mice with polyclonal IgG anti-SRBC ϩ SRBC ϩ HRBC. Controls received SRBC ϩ HRBC alone. The number of single cells producing SRBC-or HRBC-specific IgM was assayed 5 days later in a PFC assay. IgG was able to induce equally efficient suppression of the SRBC response in both strains (Fig. 1A) . Suppression was antigen-specific, because the response to the non-cross-reacting antigen, HRBC, was normal (Fig. 1 A) . To test non-epitope-specific suppression also, mice were immunized with monoclonal IgG anti-TNP ϩ SRBC-TNP ϩ HRBC. Again, the response to SRBC, but not to HRBC, was suppressed efficiently both in Fc␥RIIB Ϫ͞Ϫ and wild-type mice (Fig. 1B) . Comparison of the suppressive effect of IgG in the two strains was done altogether in 14 experiments (46 matched pairs). Plotting the responses in wild-type versus Fc␥RIIB Ϫ͞Ϫ mice show a distribution around a line with the slope 1, which is to be expected if suppression were equally efficient in both strains (Fig. 1C) . Thus, both epitope-specific and non-epitopespecific suppression is highly efficient in the absence of Fc␥RIIB at all doses of IgG tested, and no significant difference in the degree of suppression could be seen.
We (30) . The data here show that the anti-SRBC response was profoundly suppressed by IgG in animals lacking Fc␥RI ϩ III ( Fig. 2A) . FcRn transports IgG from mother to young (37) and protects IgG from catabolism in adult mice (38) . It is a heterodimer of a class I-like ␣-chain and ␤ 2 m, which also is needed for its expression (39) . FcRn is the only receptor reported to bind all subclasses of IgG (40) and was an interesting candidate because all IgG subclasses can induce suppression. However, we found no evidence for less efficient IgG-mediated suppression in ␤ 2 m Ϫ͞Ϫ mice compared with C57BL͞6 controls (Fig. 2B) . Finally, double ''knock-out'' mice lacking both FcR␥ and Fc␥RIIB were tested for suppression. We found that IgG also induced efficient suppression in these animals (Fig. 2C) .
Suppression by F(ab) 2 Fragments of IgG and by IgE. Because no involvement of Fc␥Rs in IgG-mediated suppression could be demonstrated, and because the other major Fc-mediated function of IgG, complement activation, is not required for suppression (41) , the ability of F(abЈ) 2 fragments (1999) to suppress was reinvestigated. F(abЈ) 2 fragments were prepared from purified monoclonal TNP-specific IgG2a (clone 7B4). Intact IgG was not detected in the F(abЈ) 2 preparation (Fig. 3A) , and, based on the sensitivity of the ELISA, contamination with more than 17 ng͞ml (0.006% of total protein) of intact IgG could be excluded. F(abЈ) 2 was a very efficient suppressor and inhibited almost 90% of the response at low concentrations (0.12 hemagglutination units, corresponding to 1 g͞mouse) (Fig. 3B) . This demonstrated that the Fc part of IgG is not mandatory for suppression and that F(abЈ) 2 fragments specific for one epitope can induce suppression of the response to other epitopes. Therefore, non-epitope-specific suppression cannot be used as an argument for involvement of the Fc part. Moreover, the results suggested that antibody classes other than IgG may also induce suppression. Indeed, in mice immunized with monoclonal IgE anti-TNP ϩ SRBC-TNP the magnitude of suppression was similar to that induced by a monoclonal IgG2b anti-TNP (Fig. 3C) 
DISCUSSION
We show here that IgG can efficiently inhibit antibody responses in mice lacking the known Fc receptors for IgG. The lack of any demonstrable role of Fc␥RIIB for IgG-mediated suppression was an unexpected finding. However, previous reports that IgG3 (which is unable to bind to Fc␥RIIB) can induce efficient suppression in vivo (3, 8) also argue against an exclusive role for this receptor. The antibody production in Fc␥RIIB Ϫ͞Ϫ mice after immunization with thymus-dependent and thymus-independent antigens (without IgG) is markedly enhanced, suggesting that the receptor plays an important negative regulatory role in vivo in some experimental systems (29) . We and others have found indications of Fc-receptor involvement in negative feedback regulation by IgG in vitro. Deglycosylated monoclonal IgG, unable to activate complement and to bind to Fc␥Rs, was less suppressive than glycosylated IgG (43), whereas IgG that was deficient only in classical complement activation was able to suppress (41) . Suppression could not be induced in spleen cell cultures depleted of Fc␥R-positive B cells (44) and was partially inhibited by an mAb that blocks Fc␥RIIB and III (45) . The considerable differences between in vitro and in vivo systems for studying antibody responses probably are responsible for these discrepancies. Obvious differences are the lack of lymphoid organ structure in vitro and the fact that B cells studied Proc. Natl. Acad. Sci. USA 96 (1999) in vitro are memory cells derived from spleens primed with high doses of antigen in vivo. In addition to in vitro studies, the view that IgG-mediated suppression is Fc-dependent was suggested by two types of experimental in vivo findings, both of which are controversial: the inability of F(abЈ) 2 fragments to induce suppression (4, 8, 17, 18) and the ability of IgG to induce non-epitope-specific suppression (3, 8, 18, 23) . There are many difficulties in working with F(abЈ) 2 fragments, and, in retrospect, it is hard to explain the reason for the conflicting results discussed earlier. A small contamination by intact IgG may be sufficient to induce suppression by ''F(abЈ) 2 preparations.'' Alternatively, inefficient suppression by F(abЈ) 2 could be a consequence of elimination of such fragments more rapidly than that of intact IgG because of the lack of protection by FcRn (38) . In this sense, the ability of IgG to induce suppression in vivo can be said to be Fc-dependent although the actual mechanism of action may be independent of Fc␥Rs. In the present study we have excluded contamination exceeding 1.7 ng͞mouse, a dose that does not induce suppression. The immunization schedule (preincubating antibody and antigen) minimizes the difference in elimination rate between intact IgG and F(abЈ) 2 (46) . Here, F(abЈ) 2 also induces significant suppression at concentrations as low as 1 g͞mouse. The slightly less efficient suppression by F(abЈ) 2 than by intact IgG is probably caused by a more rapid elimination of F(abЈ) 2 fragments in spite of the immunization schedule. One of the most crucial findings in the present report is that TNP-specific F(abЈ) 2 fragments can suppress the response to SRBC determinants when injected together with SRBC-TNP. This shows that, contrary to the dogma, the existence of non-epitope-specific suppression cannot be used as evidence for involvement of the Fc portions of IgG. In many experimental systems IgG must recognize an epitope present at high density on the erythrocyte surface to induce suppression (3, 23, 47) . TNP-specific monoclonal IgG, for example, can inhibit the SRBC response when given together with SRBC-TNP with a high (but not with a low) TNP density (23) . Because TNP is a small hapten (329 Da) that spontaneously couples to the -amino groups of lysine, we find it likely that it is conjugated to SRBC in a sufficiently even and dense pattern so that IgG, binding to TNP-epitopes, also will sterically hinder recognition of SRBC epitopes. On the other hand, when IgG binds to an epitope that is not so abundant, epitope-specific suppression would be expected. This interpretation leads to the conclusion that, depending on the epitope density, suppression will be epitope-or non-epitope-specific and may explain many of the discrepancies in the literature.
We demonstrate that IgE antibodies can act as negative regulators of antibody responses, adding strong support to the existence of suppression independent of the Fc-part of IgG. Involvement of the Fc part of IgE is unlikely: although IgE binds to FcRI and FcRII as well as to Fc␥RIIB and Fc␥RIII (49) , no decrease in IgE-mediated suppression of the response to SRBC-TNP was found in mice lacking these receptors (FcRII Ϫ͞Ϫ , Fc␥RIIB Ϫ͞Ϫ , FcR␥ Ϫ͞Ϫ ) (data not shown). IgM is an isotype known to enhance antibody responses (2), but at least one monoclonal IgM has been reported to suppress (8) .
There is a correlation between affinity and suppressive ability among monoclonal IgG antibodies (8) . These findings imply that all high-affinity antibodies, when present in molar excess of antigen, have the capacity to inhibit antibody responses to erythrocytes. Both IgG (23) and IgE (48) have dual immunoregulatory roles and can enhance the antibody response to soluble protein antigens. This probably takes place via increased uptake of antigen by FcRII or Fc␥Rs on antigenpresenting cells, followed by efficient presentation of peptides to T cells. In addition to increased T cell help, the molar excess of antigen present in such experimental systems would allow the triggering of B cells through their BCR, explaining why the net result is increased antibody production.
In conclusion, we have presented several novel lines of experimental evidence that suggest that negative feedback regulation of primary antibody responses by passively administered IgG in vivo is Fc-independent and probably caused by epitope masking. This model, which we are ''reintroducing,'' may seem to be at variance with many previous reports. However, if we limit the discussion to in vivo studies and accept that it is possible to get ''false'' lack of suppression using F(abЈ) 2 fragments and that, depending on the epitope density on the antigen, both epitope and non-epitope-specific suppression can be induced, the epitope-masking model is, in fact, compatible with the majority of previously published data. The greater efficiency of high-affinity antibodies and the ability of antibody classes other than IgG to suppress fit easily into the model. The relative difficulty in inhibiting induction of memory and secondary responses can be explained by unperturbed T helper cell priming. In addition, memory B cells express high-affinity receptors for antigen that probably compete more effectively with passively administered IgG than naive B cells. Finally, the stoichiometry of the process is compatible with the epitope-masking model. Ten micrograms of IgG corresponds to 4 ϫ 10 13 molecules. In mice given 10 g IgG ϩ 4 ϫ 10 . Therefore, it is plausible that the doses of IgG shown to cause suppression can do so through steric inhibition. Immunization with preformed complexes of IgG͞erythrocytes, employed in most of our experiments, hypothetically biases the experimental system toward epitope masking. However, no evidence of FcR involvement was seen when IgG was injected 1 hr before the antigen (Fig. 1 A) , making it unlikely that different immunization routes significantly alter the mechanism of suppression.
Allogeneic Rh ϩ erythrocytes presumably would be less immunogenic in humans than xenogeneic SRBC would be in mice. Therefore, the antibody response against the Rh factor can be expected to be easier to suppress than the response to SRBC, possibly explaining why doses as low as 100-300 g are sufficient to inhibit Rh immunization in clinical practice (9) . Today, Rh Ϫ women are treated with polyclonal IgG anti-Rh *CBA donor mice were primed with 50 g polyclonal SRBC-specific IgG and 4 ϫ 10 7 SRBC, or 4 ϫ 10 7 SRBC alone, or were left unprimed. Five months later, groups of eight irradiated, syngeneic recipients received 6 ϫ 10 7 spleen cells from the different groups of donors and were secondary-immunized with 4 ϫ 10 7 SRBC-NIP immediately after transfer. Five days after adoptive transfers, the antibody response in recipient mice was tested in an ELISPOT assay. This experiment was repeated once with similar results (not shown). † Mean of the log10 value of IgG anti-NIP͞SRBC (SFC͞spleen) Ϯ SD (geometrical mean) in recipients 5 days after transfer͞secondary immunization. ‡ P value vs. control value (c).
preparations derived from large pools of human immune sera. Such pools are a potential risk for infections, and the immunization of volunteers, from whom immune sera is derived, is not without complications. The presented findings may aid in the ongoing search for suppressive, monoclonal Rh-specific antibodies, where perhaps emphasis should be put on efficient antigen binding rather than on Fc-mediated properties.
